Herts and Essex Fertility - IVF Spot Purchase NCL ICB

The NHS North Central London Integrated Care Board (ICB) has completed the award stage of a procurement process titled "Herts and Essex Fertility - IVF Spot Purchase NCL ICB", under the Health Care Services (Provider Selection Regime) Regulations 2023. The procurement is classified under in vitro fertilisation services and covers the region of UKH2 in the United Kingdom. The award was made on 8 August 2025, and the contract is active.

This process, characterised as a limited procurement method executed without prior publication, signifies an award outside the conventional public contract regulations, thereby reflecting a specialised approach to service acquisition within the healthcare sector. This procurement creates an opportunity for businesses specialising in fertility services, particularly those interested in expanding their market reach within the healthcare sector. The process was straightforward, focusing mainly on price criteria and requiring no public call for competition, making it suitable for organisations that prefer direct appointments or have limited capacity for extensive bidding.

The Herts and Essex Fertility Centre Limited has been awarded the contract, underscoring opportunities for similar enterprises, especially small and medium-sized enterprises (SMEs) involved in healthcare services, to engage in niche, spot-purchase agreements, underpinning business growth through strategic public sector partnerships.